Most colorectal cancer (CRC) patients present with a microsatellite-stable phenotype. rendering them resistant to immune checkpoint inhibitors (ICIs). Among the contributors to ICI resistance. tumor-derived extracellular vesicles (TEVs) have emerged as critical players. https://parisnaturalfoodes.shop/product-category/active-liver/